First Tetrahedral Nucleic Acid Industry Development Forum

The field of life sciences is evolving rapidly, with tetrahedral nucleic acid technology at the forefront, driving future advancements in biomedicine, materials science, and nanotechnology. To further promote the translation of technological achievements and industrial innovation in this field, we are honored to announce the First Tetrahedral Nucleic Acid Industry Development Forum, scheduled to be held in Chengdu's Jinniu District in July 2024.

The forum will feature a series of keynote speeches and roundtable discussions, with distinguished guests including academicians from the Chinese Academy of Sciences, internationally renowned scholars, clinical research experts in nucleic acid tetrahedrons, and nucleic acid drug development specialists. Together, we will explore the latest trends and future directions in the industrialization of tetrahedral nucleic acid technology. We sincerely invite you to join us in witnessing and shaping the future of the tetrahedral nucleic acid industry.

Forum Date: July 7, 2024 

Forum Location: Jinniu Hotel, Chengdu

Academic Reports:

- Professor Itamar Willner, Hebrew University of Jerusalem, Israel: 

  "DNA Nanotechnology for Imaging, Controlled Targeted Drug Delivery, Gene Therapy, and Immuno-Gene Therapy"

- Professor Chengde Mao, Purdue University, USA: 

  "The Simple Side of DNA Nanotechnology"

- Professor Yunfeng Lin, West China School of Stomatology, Sichuan University: 

  "Development of Tetrahedral Framework Nucleic Acid Drugs"

- Editor Neville Compton, Small: 

  "DNA Nanotechnology in the Wiley Chemistry and Materials Journals"

Roundtable Discussion:

Future Development Directions of Framework Nucleic Acid Drugs

Keynote Reports:

- Professor De-Lun Luo, President of Yunhai Biotechnology: 

  "Applications and Industrialization Progress of Tetrahedral Nucleic Acids in Disease Fields"

- Professor Xiaoyan Ding, Zhongshan Ophthalmic Center, Sun Yat-sen University: 

  "Tetrahedral Framework Nucleic Acids in the Treatment of Retinal Diseases"

- Professor Quan-Yi Guo, Orthopedic Medical Department, PLA General Hospital: 

  "Research Progress of Tetrahedral Nucleic Acids in Bone and Cartilage Injury Repair"

- Professor Shi-Hui Zhu, Burn and Plastic Surgery Center, Shanghai Children's Medical Center: 

  "Research Progress of Tetrahedral Nucleic Acids in Skin Injury Repair"

- Mr. Song Qian, Chairman of Chuangjian Medical: 

  "Biosynthesis and Medical Aesthetic Applications of Tetrahedral Nucleic Acids"

- Editor Xie Wen, Small Methods: 

  "Publishing in Wiley Materials Science Journals"